|
MEGF9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.49009999953032E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.995700E-04 |
| Normal-vs-Stage2 |
2.343600E-03 |
| Normal-vs-Stage3 |
4.648400E-04 |
| Normal-vs-Stage4 |
1.251770E-02 |
| Stage1-vs-Stage2 |
7.284600E-01 |
| Stage1-vs-Stage3 |
3.162200E-01 |
| Stage1-vs-Stage4 |
3.777200E-01 |
| Stage2-vs-Stage3 |
5.543800E-01 |
| Stage2-vs-Stage4 |
5.287200E-01 |
| Stage3-vs-Stage4 |
9.211800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.03720000044616E-07 |
| Normal-vs-AfricanAmerican |
3.277500E-02 |
| Normal-vs-Asian |
5.29060000253878E-08 |
| Caucasian-vs-AfricanAmerican |
3.473800E-01 |
| Caucasian-vs-Asian |
2.335600E-02 |
| AfricanAmerican-vs-Asian |
7.720800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.50760523456961E-11 |
| Normal-vs-Female |
6.957200E-01 |
| Male-vs-Female |
7.377400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.528390E-01 |
| Normal-vs-Extreme_Weight |
7.50570000040973E-07 |
| Normal-vs-Obese |
9.099800E-02 |
| Normal-vs-Extreme_Obese |
1.396640E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.498800E-01 |
| Normal_Weight-vs-Obese |
8.465200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.561010E-01 |
| Extreme_Weight-vs-Obese |
7.518400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.061000E-01 |
| Obese-vs-Extreme_Obese |
5.649800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.825830E-01 |
| Normal-vs-Age(41-60Yrs) |
2.730300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.03699970622051E-10 |
| Normal-vs-Age(81-100Yrs) |
5.966000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.809200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.311600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.392400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.401500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.583400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.940000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.15830000000117E-06 |
| Normal-VS-Type2 PRCC |
5.122800E-03 |
| Normal-VS-KIRP CIMP |
6.472400E-02 |
| Normal-VS-Unclassified PRCC |
3.5037000000071E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.710600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.576200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.916200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.529600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.233600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.139400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.94679999974279E-07 |
| Normal-vs-N1 |
8.774100E-04 |
| Normal-vs-N2 |
3.902000E-01 |
| N0-vs-N1 |
9.742600E-01 |
| N0-vs-N2 |
8.164800E-01 |
| N1-vs-N2 |
8.275000E-01 |
|
|
